Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00976573
Title Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Alliance for Clinical Trials in Oncology
Indications

melanoma

Therapies

Bevacizumab + Carboplatin + Paclitaxel

Bevacizumab + Carboplatin + Everolimus + Paclitaxel

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.